Invention Grant
- Patent Title: Quinazolinones as bromodomain inhibitors
-
Application No.: US14908898Application Date: 2014-07-30
-
Publication No.: US09855271B2Publication Date: 2018-01-02
- Inventor: John Frederick Quinn , Vladimir Khlebnikov
- Applicant: Zenith Epigenetics Ltd.
- Applicant Address: CA Calgary, AB
- Assignee: Zenith Epigenetics Ltd.
- Current Assignee: Zenith Epigenetics Ltd.
- Current Assignee Address: CA Calgary, AB
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- International Application: PCT/IB2014/002510 WO 20140730
- International Announcement: WO2015/015318 WO 20150205
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/5377 ; C07D401/04 ; C07D401/12 ; C07D405/12 ; C07D239/91 ; C07D471/04 ; A61K31/517 ; A61K45/06 ; C07D403/12
Abstract:
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
Public/Granted literature
- US20160193218A1 NOVEL QUINAZOLINONES AS BROMODOMAIN INHIBITORS Public/Granted day:2016-07-07
Information query
